Recent News

• 03.13.2025 - Akebia’s Fourth Quarter 2024 Financial Results
• 03.13.2025 - Akebia’s Fourth Quarter 2024 Financial Results
• 03.06.2025 - Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights
• 03.06.2025 - Akebia Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Discuss Recent Business Highlights
• 03.04.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.04.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 02.04.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 02.04.2025 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 03.03.2025 - 144 Report of proposed sale of securities
• 03.03.2025 - 144 Report of proposed sale of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - 8-K Current report
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2025 - 144 Report of proposed sale of securities